Head-to-head · Cost-Efficiency Index
Bodi Envi vs InstaRX
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Bodi Envi
Cost-first shoppers who want flat all-dose compounded pricing from a clinic with a named, checkable founder history.
Visit Bodi EnviInstaRX
Cost-first shoppers who want one flat price at every dose, for shoppers who don't want to guess what a dose increase will cost.
Visit InstaRXThe verdict
Bodi Envi and InstaRX tie on the Cost-Efficiency Index at 67/100, so neither wins outright on the numbers. For most shoppers we'd start with Bodi Envi (ranked #132, a hair above #139) — Cost-first shoppers who want flat all-dose compounded pricing from a clinic with a named, checkable founder history. But InstaRX is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Bodi Envi.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Bodi Envi | InstaRX |
|---|---|---|
| Cost-Efficiency Index | 67/100 | 67/100 |
| Semaglutide / mo | $169/mo (all doses, compounded) | $179/mo |
| Tirzepatide / mo | $249/mo (all doses, compounded) | $259/mo |
| Semaglutide / yr (modeled) | $2,028 | $2,148 |
| Tirzepatide / yr (modeled) | $2,988 | $3,108 |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #132 | #139 |
Bodi Envi
67/100Where the value is
- Real, named founders (Ashley and Shaun Padgett) with a verifiable brick-and-mortar practice (Padgett Medical Center, Florida) and a large public review history
- Flat, transparent per-drug pricing with no doses-based escalation shown on the pricing cards
- No consultation or membership fee visible on the pricing page
The tradeoffs
- A prior automated pull of this site reported different (lower, promo-flavored) prices than what the page visually shows today — pricing pages on this domain appear to change, so re-verify at time of use
- States served are not explicitly listed on the pages read this session
InstaRX
67/100Where the value is
- Flat 'same price any dose' model for both drugs ($179/mo semaglutide, $259/mo tirzepatide) — no dose-tier guesswork
- Free expedited shipping stated explicitly
- States medications come 'exclusively from U.S. pharmacies'
The tradeoffs
- The homepage's own '$199 to get started' figure is never explained anywhere on the site — unclear if it's a one-time signup charge, the first month's payment, or an additional charge on top of the $179/$259 monthly prices
- No medical director or named prescriber anywhere — only generic 'third-party professional healthcare providers' language
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.